Top 5 Long Term Companies To Buy For 2015

Search Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener.

NEW YORK (TheStreet) -- Does the next Federal Reserve chairman really matter to the stock market? Jim Cramer told his "Mad Money" viewers Monday that over the long term, probably not that much. But for those shorting the markets going into this past weekend, it mattered a great deal.

Cramer explained that the only thing that stands in the way of higher stock prices is Washington. That's why the thought of the ever-polarizing Larry Summers taking the helm of the Fed had the bears betting big that a Summers appointment, along with other disappointing news from the Fed this week, would surely take the markets sharply lower.

Top 5 Long Term Companies To Buy For 2015: Express Scripts Holding Co (ESRX)

Express Scripts Holding Company, incorporated in 2011, provides healthcare management and administration services on behalf of its clients, which include health maintenance organizations (HMOs), health insurers, third-party administrators, employers, union-sponsored benefit plans, workers compensation plans, and government health programs. The Company operates in two segments: Pharmacy Benefit Management (PBM) and Emerging Markets (EM). PBM services include network claims processing, home delivery services, patient care and direct specialty and fertility home delivery to patients, benefit plan design consultation, drug utilization review, formulary management, drug data analysis services, distribution of injectable drugs to patients homes and physicians offices, bio-pharma services, and fulfillment of prescriptions to low-income patients through manufacturer-sponsored patient assistance programs. EM segment provides distribution of pharmaceuticals and medical supplies to providers and clinics, healthcare account administration and implementation of consumer-directed healthcare solutions. In September 2013, it announced the acquisition of the SmartD Medicare Prescription Drug Plan (PDP).

On July 20, 2011, Express Scripts, Inc. (ESI) entered into a merger agreement (the Merger Agreement) with Medco Health Solutions, Inc. (Medco). During the year ended December 31, 2011, it reorganized its FreedomFP line of business from its EM segment into its PBM segment. On April 2, 2012, the Company completed the Merger Agreement, and after which ESI and Medco became the wholly owned subsidiaries of the Company. The Company�� customers include HMOs, health insurers, third-party administrators, employers, union-sponsored benefit plans, government health programs, office-based oncologists, renal dialysis clinics, ambulatory surgery centers, primary care physicians, retina specialists and others.

Advisors' Opinion:

• [By Seth Jayson]

  Express Scripts Holding (Nasdaq: ESRX  ) is expected to report Q2 earnings on July 29. Here's what Wall Street wants to see:

  The 10-second takeaway
  Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Express Scripts Holding's revenues will wither -7.9% and EPS will grow 25.0%.

• [By Adam Levine-Weinberg]

  Strong results, modest outlook
  Rite Aid's profit was driven by three major one-time or short-term impacts. First, the company gained a number of new customers from Walgreen's dispute with pharmacy benefits manager Express Scripts (NASDAQ: ESRX  ) . Walgreen's stores rejoined the Express Scripts network as of Sept. 15, and customers are beginning to trickle back, but Rite Aid still saw a significant benefit from the dispute in fiscal year 2013. On Rite Aid's Thursday morning conference call, executives estimated the full-year benefit at $70 million�-- more than half of the company's fiscal year 2013 profit.

• [By Alexander J. Poulos]

  Script count, a metric used to determine the health of the pharmacy business is showing tremendous growth which augurs well for the future health of the company. Particularly impressive is the roughly 1% market share gain. WAG needs to continue to win back the business lost during the messy Express Scripts (ESRX) battle that was waged last year.

• [By Holly LaFon]

  Their largest holdings as of the end of the second quarter are Apple (AAPL), Berkshire Hathaway (BRK.A)(BRK.B), Google (GOOG), Express Scripts (ESRX) and Qualcomm (QCOM).

Top 5 Long Term Companies To Buy For 2015: Albemarle Corp (ALB)

Albemarle Corporation (Albemarle), incorporated in 1993, is a developer, manufacturer and marketer of specialty chemicals, which meet customer needs across a range of end markets, including the petroleum refining, consumer electronics, plastics/packaging, construction, automotive, lubricants, pharmaceuticals, crop protection, food-safety and custom chemistry services markets. As of December 31, 2011, the Company and its joint ventures operated 50 facilities, encompassing production, research and development facilities, and administrative and sales offices in North and South America, Europe, the Middle East, Asia, Africa and Australia. It serves approximately 3,000 customers in over 100 countries. It operates in three segments: Polymer Solutions, Catalysts and Fine Chemistry. On May 11, 2011, the Company acquired Catilin Inc. In October 2013, Albemarle Corp acquired Cambridge Chemical Co Ltd.

Polymer Solutions

The Company�� Polymer Solutions segment consists of two product market categories: flame retardants and stabilizers and curatives. Its products include plastic enclosures for consumer electronics, printed circuit boards, wire and cable, electrical connectors, textiles, foam insulation, and foam seating in furniture and automobiles. Its brominated flame retardants include products such as Saytex; its mineral-based flame retardants include products, such as Martinal and Magnifin, and its phosphorus-based flame retardants include products, such as Antiblaze and Ncendx.

The Company produces plastic additives, as well as other additives, such as curatives, antioxidants and stabilizers. Its additives products include curatives for polyurethane, polyurea, and epoxy system polymerization. This business also produces antioxidants and stabilizers. Its Ethacure curatives are used in cast elastomers, coatings, reaction injection molding (RIM) and specialty adhesives, which are incorporated into products, such as wheels, tires and rollers. Its line of Ethanox antioxi! dants is used by manufacturers of polyolefins to maintain physical properties during the manufacturing process, including the color of the final product. These antioxidants are found in applications, such as slit film, wire and cable, food packaging and pipes.

The Company produces antioxidants used in fuels and lubricants. Its line of Ethanox fuel and lubricant antioxidants is used by refiners and fuel marketers to extend fuel storage life and protect fuel systems, and by oil marketers and lubricant manufacturers to extend the useful life of lubricating oils, fluids and greases used in engines and various types of machinery. Its polymer solutions segment offers more than 80 products to a range of end-markets. It sells its products to chemical manufacturers and processors, such as polymer resin suppliers, lubricant manufacturers, refiners and other specialty chemical companies.

The Company competes with Chemtura Corporation, Israel Chemicals Ltd, Jiangsu Yoke Technology Co., Ltd., Zhejiang Wansheng Chemical Co., Ltd., J.M. Huber Corporation, Kyowa Chemical Industry Co., Ltd., Nabaltec GmbH, BASF Corporation, Chemtura Corporation and Songwon Industrial Co., Ltd.,

Catalysts

The Company�� Catalysts segment includes its refinery catalysts and catalyst solutions businesses. Its main refinery catalysts product lines are hydroprocessing catalysts (HPC), and fluidized catalytic cracking (FCC), catalysts and additives. HPC catalysts are used to reduce the quantity of sulfur and other impurities in petroleum products, as well as to convert feedstock into lighter products. FCC catalysts assist in the cracking of petroleum streams into derivative, higher-value products, such as fuels and petrochemical feedstock. Its FCC additives are used to remove sulfur in gasoline and to reduce emissions of sulfur dioxide and nitrogen oxide in FCC units. It offers approximately 130 different HPC catalysts products and approximately 40 different FCC catalysts and additives pro! ducts to ! its customers.

The Company has three business units in its performance catalyst solutions (PCS) division: polymer catalysts, chemical catalysts and electronic materials. It manufactures organometallic co-catalysts, as well as metallocene components and co-catalysts. It also offers finished Single-Site catalysts with or without its ActivCat technology and a range of Ziegler-Natta catalysts under the Advantage brand. Its co-catalysts and finished catalysts are used in its customers��production of polyolefin polymers. Such polymers are commodity (Ziegler Natta polymerization technology) and specialty (Single Site polymerization technology) plastics serving a range of end markets, including packaging, non-packaging, films and injection molding. Some of its organometallic products are also used in the manufacture of alpha-olefins (hexene, octane and decene). In electronic materials, it manufacture and sells metal organic products into electronic applications, such as the production of light emitting diodes (LEDs) for displays and general lighting, as well as other products used in the production of solar cells. Its chemical catalysts include a range of catalysts used in the chemical industry.

The Company competes with Criterion Catalysts and Technologies, W.R. Grace & Co./Advanced Refining Technologies, Haldor Topsoe, W.R. Grace & Co., BASF Corporation, AkzoNobel and Chemtura Corporation.

Fine Chemistry

The Company�� Fine Chemistry segment consists of two categories: performance chemicals, and fine chemistry services and intermediates. Performance chemicals include products, such as elemental bromine, alkyl bromides, inorganic bromides, brominated powdered activated carbon and a range of bromine fine chemicals. Its products are used in chemical synthesis, oil and gas well drilling and completion fluids, mercury control, paper manufacturing, water purification, beef and poultry processing and other industrial applications. Other performance chemicals, wh! ich it pr! oduces include tertiary amines for surfactants, biocides, disinfectants and sanitizers; potassium-based products used in industrial applications; alkenyl succinic anhydride used in paper-sizing formulations, and aluminum oxides used in a range of refractory, ceramic and polishing applications. It sells these products to customers globally for use in personal care products, automotive insulation, foundry bricks and other industrial products.

The Company�� fine chemistry services business offers custom manufacturing, research and chemical scale-up services for companies. Its pharmaceutical bulk active is ibuprofen. Ibuprofen is used to provide pain relief and fever reduction. Bulk ibuprofen is formulated by pharmaceutical companies, which sells in both the prescription and over-the-counter markets. The Company also produces a range of intermediates used in the manufacture of a range of over-the-counter and prescription drugs.

The Company�� agrichemicals are sold to agrichemical manufacturers and distributors, which produce and distribute finished agricultural herbicides, insecticides, fungicides and soil fumigants. Its products include orthoalkylated anilines used in the acetanilide family of pre-emergent herbicides used with corn, soybeans and other crops and methyl bromide, which is used as a soil fumigant. It also manufactures and supplies a range of custom chemical intermediates for the agricultural industry.

The Company competes with Chemtura Corporation, Israel Chemicals, BASF Corporation, Lonza, Clariant Ltd. and Cilag AG.

Advisors' Opinion:

• [By Marc Bastow]

  Specialty chemicals developer, manufacturer and distributor Albemarle (ALB) raised its quarterly dividend 15% to 27.5 cents per share, payable April 1 to shareholders of record as of March 14.
  ALB Dividend Yield: 1.66%

• [By Seth Jayson]

  Albemarle (NYSE: ALB  ) reported earnings on July 17. Here are the numbers you need to know.

  The 10-second takeaway
  For the quarter ended June 30 (Q2), Albemarle missed estimates on revenues and met expectations on earnings per share.

5 Best Quality Stocks To Own Right Now: Medbox Inc (MDBX)

Medbox Inc. (Medbox) offers a machine that dispenses medication to individuals based on biometric identification (fingerprint sample). The machine allows pharmacies, hospitals, doctors' offices, and alternative medicine clinics to manage employee possession of sensitive drugs. The system also allows these clinics to demonstrate that the user visiting the machine is a registered patient and that the patient has a valid and unexpired authorization from a physician to possess and use the medicine dispensed. The Company has national and international presence with offices in Los Angeles, New York, Toronto, London and Tokyo.

Medbox, through its subsidiaries, offers consulting services to the alternative medicine industry, as well as to the mini self-storage market. The Company provides consulting services primarily to individuals and groups seeking to establish new clinics and facilities, often in jurisdictions that have recently passed legislation concerning the availability of alternative medicines, as well as existing jurisdictions, nationwide.

Advisors' Opinion:

• [By James E. Brumley]

  Wow. That didn't take long. It was only two days ago that marijuana stocks like Growlife Inc. (OTCBB:PHOT), Medical Marijuana Inc. (OTCMKTS:MJNA), Cannabis Science Inc. (OTCMKTS:CBIS), Medbox Inc. (OTCMKTS:MDBX), and Hemp, Inc. (OTCMKTS:HEMP) were all the rage, flying high on the heels of a new year... a new year in which marijuana was legalized (for one reason or another) in two more states. HEMP was up as much as 700% in less than three weeks at one point. MDBX gained 300% at the beginning of the year, when recreational marijuana began to be legally sold in Colorado. CBIS jumped 400% off of its December low. MJNA nearly doubled on the advent of new marijuana venues. PHOT soared more than 130% since the end of last year on the legalization of marijuana. It was, truthfully, some of the fastest big money that traders have ever made in the market.

• [By Ben Levisohn]

  But, as the Huffington Post points out, most of the companies that stand to benefit are very small–they make micro caps look big–trade over the counter–good bye liquidity. That includes transaction-processing company MediSwipe (MWIPD), GreenGro Technologies (GRNH) Medbox (MDBX), which makes dispenser for high-risk drugs, and GW Pharmaceuticals (GWPRF).

• [By John Udovich]

  Small cap marijuana stocks Medical Marijuana Inc (OTCMKTS: MJNA), Cannabis Science Inc (OTCMKTS: CBIS), Medbox Inc (OTCMKTS: MDBX), Growlife Inc (OTCBB: PHOT) and HEMP, Inc (OTCMKTS: HEMP) were all surging by double digits yesterday thanks in part to legal sales of pot beginning in Colorado.

• [By Bryan Murphy]

  The last few days have been nothing less than incredible for stocks like Cannabis Science Inc. (OTCMKTS:CBIS), Medbox Inc. (OTCMKTS:MDBX), Growlife Inc. (OTCBB:PHOT), and Medical Marijuana Inc. (OTCMKTS:MJNA). MJNA shares have jumped 90% since last Friday. PHOT is up 51% for the same timeframe. CBIS has grown 150%, while MDBX is up 112%. The reason? It's largely the legalization of recreational marijuana in Colorado - a law that went into effect as of January 1st. The legalization of medical marijuana in Illinois on the same day didn't hurt either. And truth be told, the event-based rally from the likes of Medbox and Cannabis Science makes basic sense - it's a landmark shift in the way this country views and treats marijuana. On the flipside, before wading any deeper into stocks like Medical Marijuana or Growlife, current and would-be owners might want to take a step back and look at the bigger picture.

Top 5 Long Term Companies To Buy For 2015: Regeneron Pharmaceuticals Inc.(REGN)

Regeneron Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes pharmaceutical products for the treatment of serious medical conditions in the United States. The company?s commercial product includes ARCALYST (rilonacept) injection for subcutaneous use for the treatment of cryopyrin-associated periodic syndromes, including familial cold auto-inflammatory syndrome and muckle-wells syndrome in adults and children. Its products under Phase III clinical development stage consist of VEGF Trap-Eye, an aflibercept ophthalmic solution developed using intraocular delivery for the treatment of serious eye diseases; ARCALYST for the prevention of gout flares in patients initiating uric acid-lowering treatment; and Aflibercept (VEGF Trap), which is developed in oncology. The company?s earlier stage clinical programs include various human antibodies, such as REGN727 for low-density lipoprotein cholesterol reduction, REGN88 for rheumatoid arthritis and ankylosing spondylitis; REGN668 for atopic dermatitis and asthma; REGN421 and REGN910 for oncology; REGN475 for the treatment of pain; and REGN728 and REGN846. It also conducts preclinical research programs in the areas of oncology and angiogenesis, ophthalmology, metabolic and related diseases, muscle diseases and disorders, inflammation and immune diseases, bone and cartilage, pain, cardiovascular diseases, and infectious diseases. The company distributes its products through third party service providers. It has strategic collaboration with sanofi-aventis Group to discover, develop, and commercialize human monoclonal antibodies; and Bayer HealthCare LLC to develop and commercialize VEGF Trap. Regeneron Pharmaceuticals, Inc. was founded in 1988 and is based in Tarrytown, New York.

Advisors' Opinion:

• [By Ben Levisohn]

  Earlier today, the S&P 500 looked like it would close at an all-time high. Then the bears roared, and S&P 500 gave back about half its gains despite big moves in United Health (UNH), Humana (HUM), Pioneer Natural Resources (PXD),�ExxonMobil (XOM) and� Regeneron (REGN).

• [By Hilary Kramer]

  I��e long been a fan of Regeneron (REGN), and have recommended it in recent years to my own investment newsletter subscribers.� The company�� shares have risen by roughly 70% in the past year, besting the market and pacing the 66% rise in 2013 for the biotech sector.� At a recent $290 a share, REGN should outperform the market in the near term, rising double digits to the mid $300 level.

• [By Ben Levisohn]

  Lower cholesterol means a higher price for Amgen’s (AMGN) stock–but could be bad news for Regeneron Pharmaceuticals (REGN).

  Shares of Amgen have gained 2% to $122.95 today after the biotech giant said that a trial showed it’s cholesterol drug works better than a placebo. Reuters has the details:

Top 5 Long Term Companies To Buy For 2015: Nationstar Mortgage Holdings Inc (NSM)

Nationstar Mortgage Holdings Inc. is a non-bank residential mortgage servicer with a range of services across the residential mortgage product spectrum. As of December 31, 2011, the Company serviced over 645,000 residential mortgage loans. The Company�� clients include national and regional banks, government organizations, securitization trusts, private investment funds and other owners of residential mortgage loans and securities. It is a partner of financial organizations, including government-sponsored enterprises (GSEs) and other regulated institutions. The Company is a licensed servicer in all 50 states. In addition to its core servicing business, the Company has a fully integrated loan originations platform and suite of adjacent businesses.

Nationstar offers clients a range of services. The Company combines its mortgage servicing with a fully integrated loan originations platform. Nationstar offers clients a diversified array of residential mortgage services: Servicing, Originations and Other Related Services.

Servicing

The Company offers mortgage investors two primary ways to partner. A portion of its portfolio consists of owned mortgage servicing rights (MSRs). In this arrangement, the Company owns the right to collect the principal and interest due from a mortgage borrower, as well as manage the title and property insurance escrow of the collateral on behalf of mortgage investors in exchange for a monthly fee proportional to the unpaid principle balance (UPB) of the mortgage. The Company acquires MSRs either through its own origination of mortgages or by acquiring these rights from other MSR owners or the mortgage investor. It subservices multiple portfolios for federal agencies, Government Sponsored Enterprises (GSEs) and large banks. For its subservicing clients, the Company is organized to serve its clients with an Investor Collections Professional and Senior Portfolio Manager(s) assigned to each portfolio.

Originations

The! Company offers a fully integrated loan origination platform. It also operates a wholesale origination channel capable of purchasing loans primarily from Financial Institutions operating as a broker.

Other Related Services

The Company offers a full suite of additional residential mortgage services to complement its servicing business and supporting originations platform. These businesses offer a range of ancillary services, including providing services for delinquent loans, managing loans in the foreclosure/real estate owned (REO) process and providing title insurance agency, loan settlement and valuation services on newly originated and re-originated loans. Nationstar is a part owner in NREIS, which is a provider of residential and commercial mortgage and real estate solutions in the United States. Their services include title insurance and property reports; real estate appraisals and alternative valuation products; settlement and closing services; commercial real estate services; default and property preservation services, and flood and tax certifications.

Advisors' Opinion:

• [By Dakin Campbell]

  Servicing rights on at least $1 trillion of mortgages will trade in the next two years, Jay Bray, chief executive officer of Nationstar Mortgage Holdings Inc. (NSM), a servicer majority owned by Fortress Investment Group LLC (FIG), said last month. The private-equity firm said in July it raised a $1.1 billion fund to buy the contracts.

• [By Christina Rexrode]

  Nationstar Mortgage Holdings Inc. (NSM) was down nearly 2%. The mortgage servicer had jumped 5% Wednesday. It told investors then that it expected a fourth-quarter loss from one-time charges, but reaffirmed its full-year earnings predictions, said Jefferies analyst Daniel Furtado.